108 related articles for article (PubMed ID: 38860162)
1. Clinical and Molecular Characteristics of Megakaryocytes in Myelodysplastic Syndrome.
Luo F; Zhao J; Chen Y; Peng Z; An R; Lu Y; Li J
Glob Med Genet; 2024 Jun; 11(2):187-195. PubMed ID: 38860162
[No Abstract] [Full Text] [Related]
2. Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome.
Larocca LM; Heller PG; Podda G; Pujol-Moix N; Glembotsky AC; Pecci A; Alberelli MA; Balduini CL; Landolfi R; Cattaneo M; De Candia E
Platelets; 2015; 26(8):751-7. PubMed ID: 25806575
[TBL] [Abstract][Full Text] [Related]
3. Presence of intra-tumoral CD61+ megakaryocytes predicts poor prognosis in non-small cell lung cancer.
Huang W; Zhao S; Xu W; Zhang Z; Ding X; He J; Liang W
Transl Lung Cancer Res; 2019 Aug; 8(4):323-331. PubMed ID: 31555508
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].
Hu T; Shi XD; Feng YL; Liu R; Li JH; Chen J; Wang TY
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):183-7. PubMed ID: 15833188
[TBL] [Abstract][Full Text] [Related]
5. Effects of cytokines on platelet production from blood and marrow CD34+ cells.
Norol F; Vitrat N; Cramer E; Guichard J; Burstein SA; Vainchenker W; Debili N
Blood; 1998 Feb; 91(3):830-43. PubMed ID: 9446643
[TBL] [Abstract][Full Text] [Related]
6. Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes.
Hofmann WK; Kalina U; Wagner S; Seipelt G; Ries C; Hoelzer D; Ottmann OG
Exp Hematol; 1999 Mar; 27(3):395-400. PubMed ID: 10089900
[TBL] [Abstract][Full Text] [Related]
7. In vitro biological characteristics of human cord blood-derived megakaryocytes.
Sun L; Tan P; Yap C; Hwang W; Koh LP; Lim CK; Aw SE
Ann Acad Med Singap; 2004 Sep; 33(5):570-5. PubMed ID: 15531951
[TBL] [Abstract][Full Text] [Related]
8. Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents.
Liu Y; Wang Y; Gao Y; Forbes JA; Qayyum R; Becker L; Cheng L; Wang ZZ
Stem Cells Transl Med; 2015 Apr; 4(4):309-19. PubMed ID: 25713465
[TBL] [Abstract][Full Text] [Related]
9. Gene and protein expression in human megakaryocytes derived from induced pluripotent stem cells.
Kammers K; Taub MA; Mathias RA; Yanek LR; Kanchan K; Venkatraman V; Sundararaman N; Martin J; Liu S; Hoyle D; Raedschelders K; Holewinski R; Parker S; Dardov V; Faraday N; Becker DM; Cheng L; Wang ZZ; Leek JT; Van Eyk JE; Becker LC
J Thromb Haemost; 2021 Jul; 19(7):1783-1799. PubMed ID: 33829634
[TBL] [Abstract][Full Text] [Related]
10. miR-15a-5p regulates expression of multiple proteins in the megakaryocyte GPVI signaling pathway.
Basak I; Bhatlekar S; Manne BK; Stoller M; Hugo S; Kong X; Ma L; Rondina MT; Weyrich AS; Edelstein LC; Bray PF
J Thromb Haemost; 2019 Mar; 17(3):511-524. PubMed ID: 30632265
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand.
Cramer EM; Norol F; Guichard J; Breton-Gorius J; Vainchenker W; Massé JM; Debili N
Blood; 1997 Apr; 89(7):2336-46. PubMed ID: 9116277
[TBL] [Abstract][Full Text] [Related]
12. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
[TBL] [Abstract][Full Text] [Related]
13. CD34+ megakaryocytes (≥30%) are associated with megaloblastic anaemia and non-acute myeloid neoplasia.
Insuasti-Beltran G; Steidler NL; Kang H; Reichard KK
Histopathology; 2012 Oct; 61(4):694-701. PubMed ID: 22651817
[TBL] [Abstract][Full Text] [Related]
14. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.
Proulx C; Boyer L; Hurnanen DR; Lemieux R
J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177
[TBL] [Abstract][Full Text] [Related]
15. Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture.
Guerriero R; Testa U; Gabbianelli M; Mattia G; Montesoro E; Macioce G; Pace A; Ziegler B; Hassan HJ; Peschle C
Blood; 1995 Nov; 86(10):3725-36. PubMed ID: 7579339
[TBL] [Abstract][Full Text] [Related]
16. CD34+ cells derived from fetal liver contained a high proportion of immature megakaryocytic progenitor cells.
Ma DC; Sun YH; Zuo W; Chang KZ; Chu JJ; Liu YG
Eur J Haematol; 2000 May; 64(5):304-14. PubMed ID: 10863976
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional characterization of human megakaryocyte polyploidization and lineage commitment.
Choudry FA; Bagger FO; Macaulay IC; Farrow S; Burden F; Kempster C; McKinney H; Olsen LR; Huang N; Downes K; Voet T; Uppal R; Martin JF; Mathur A; Ouwehand WH; Laurenti E; Teichmann SA; Frontini M
J Thromb Haemost; 2021 May; 19(5):1236-1249. PubMed ID: 33587817
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo expansion of CD34+/CD41+ late progenitors from enriched peripheral blood CD34+ cells.
Halle P; Rouzier C; Kanold J; Boiret N; Rapatel C; Mareynat G; Tchirkov A; Berger M; Travade P; Bonhomme J; Deméocq F
Ann Hematol; 2000 Jan; 79(1):13-9. PubMed ID: 10663616
[TBL] [Abstract][Full Text] [Related]
19. Role of Long Non-Coding RNAs in Human-Induced Pluripotent Stem Cells Derived Megakaryocytes: A p53, HOX Antisense Intergenic RNA Myeloid 1, and miR-125b Interaction Study.
Dahariya S; Raghuwanshi S; Thamodaran V; Velayudhan SR; Gutti RK
J Pharmacol Exp Ther; 2023 Jan; 384(1):92-101. PubMed ID: 36243404
[TBL] [Abstract][Full Text] [Related]
20. Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets.
Schmitt A; Guichard J; Massé JM; Debili N; Cramer EM
Exp Hematol; 2001 Nov; 29(11):1295-302. PubMed ID: 11698125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
